POLYDEXA, ear solution, drops bottle, 10.5 ml
Brand page: Polydexa (neomycin + polymyxin B + dexamethasone) — all forms and strengths in France
Active ingredients: Dexamethasone sodium metasulfobenzoate, Neomycin sulfate, Polymyxin b1 sulfate
Commercialized according to BDPMDispensing in France: Prescription only
Solution dropsbottle, 10.5 mlauriculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- POLYDEXA, solution auriculaire, gouttes
- Pharmaceutical form
- solution gouttes
- Route of administration
- auriculaire
- Presentation description
- 1 flacon(s) de 10,5 ml avec compte-gouttes
- Marketing authorisation holder
- BOUCHARA-RECORDATI
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Sept 1973
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66129490CIP73153342CIP133400931533429Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| POLYMYXINE B (SULFATE DE)solution | 1 000 000 U · 100 ml | SA |
| DEXAMÉTHASONE (MÉTASULFOBENZOATE SODIQUE DE)solution | 0,100 g · 100 ml | SA |
| NÉOMYCINE (SULFATE DE)solution | 650 000 U · 100 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.